Cargando…

The Potential Use of DNA Methylation Biomarkers to Identify Risk and Progression of Type 2 Diabetes

Type 2 diabetes mellitus (T2D) is a slowly progressive disease that can be postponed or even avoided through lifestyle changes. Recent data demonstrate highly significant correlations between DNA methylation and the most important risk factors of T2D, including age and body mass index, in blood and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gillberg, Linn, Ling, Charlotte
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2015
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4378313/ https://www.ncbi.nlm.nih.gov/pubmed/25870586 http://dx.doi.org/10.3389/fendo.2015.00043

Ejemplares similares

Blood-Based DNA Methylation Biomarkers for Type 2 Diabetes: Potential for Clinical Applications
por: Willmer, Tarryn, et al.
Publicado: (2018)

Corrigendum: Blood-Based DNA Methylation Biomarkers for Type 2 Diabetes: Potential for Clinical Applications
por: Willmer, Tarryn, et al.
Publicado: (2019)

Biomarkers for Detecting Kidney Dysfunction in Type-2 Diabetics and Diabetic Nephropathy Subjects: A Case-Control Study to Identify Potential Biomarkers of DN to Stratify Risk of Progression in T2D Patients
por: Harkin, Carla, et al.
Publicado: (2022)

Integrative Analysis of DNA Methylation and Gene Expression Identified Follicular Thyroid Cancer-Specific Diagnostic Biomarkers
por: Yao, Yunjin, et al.
Publicado: (2022)

Mini-review: Mitochondrial DNA methylation in type 2 diabetes and obesity
por: Rautenberg, Emma K., et al.
Publicado: (2022)

Genomic DNA Methylation in Diabetic Chronic Complications in Patients With Type 2 Diabetes Mellitus
por: Wang, Xixi, et al.
Publicado: (2022)

Circulating biomarkers during progression to type 1 diabetes: A systematic review
por: Brenu, Ekua W., et al.
Publicado: (2023)

Gene Expression Analysis of the Pre-Diabetic Pancreas to Identify Pathogenic Mechanisms and Biomarkers of Type 1 Diabetes
por: Yip, Linda, et al.
Publicado: (2020)

Optimizing strategies to identify high risk of developing type 2 diabetes
por: Bracco, Paula Andreghetto, et al.
Publicado: (2023)

Is the level of serum lactate dehydrogenase a potential biomarker for glucose monitoring with type 2 diabetes mellitus?
por: Hsieh, Yu-Shan, et al.
Publicado: (2022)

Integrative analysis reveals novel associations between DNA methylation and the serum metabolome of adolescents with type 2 diabetes: A cross-sectional study
por: Agarwal, Prasoon, et al.
Publicado: (2022)

Zinc finger and SCAN domain-containing protein 18 is a potential DNA methylation-modified tumor suppressor and biomarker in breast cancer
por: Wang, Yu, et al.
Publicado: (2023)

Bioinformatics Analysis Identifies Potential Ferroptosis Key Gene in Type 2 Diabetic Islet Dysfunction
por: Ye, Haowen, et al.
Publicado: (2022)

Cardiac Autonomic Dysfunction Is Associated With Risk of Diabetic Kidney Disease Progression in Type 2 Diabetes Mellitus
por: Zeng, Haixia, et al.
Publicado: (2022)

microRNAs as Potential Biomarkers in Adrenocortical Cancer: Progress and Challenges
por: Cherradi, Nadia
Publicado: (2016)

Editorial: Novel Biomarkers for Type 2 Diabetes
por: Ahluwalia, Tarunveer S., et al.
Publicado: (2019)

Identifying potential biomarkers for non-obstructive azoospermia using WGCNA and machine learning algorithms
por: Tang, Qizhen, et al.
Publicado: (2023)

Metabolomic Profiling of Poor Ovarian Response Identifies Potential Predictive Biomarkers
por: Song, Haixia, et al.
Publicado: (2021)

REG1A and RUNX3 Are Potential Biomarkers for Predicting the Risk of Diabetic Kidney Disease
por: Wang, Xinyu, et al.
Publicado: (2022)

Inflammation, oxidative stress and mitochondrial dysfunction in the progression of type II diabetes mellitus with coexisting hypertension
por: Yousef, Hibba, et al.
Publicado: (2023)

Does DNA Methylation of PPARGC1A Influence Insulin Action in First Degree Relatives of Patients with Type 2 Diabetes?
por: Gillberg, Linn, et al.
Publicado: (2013)

DNA methylation profiling reveals novel pathway implicated in cardiovascular diseases of diabetes
por: Hu, Shengqing, et al.
Publicado: (2023)

Machine learning identifies ferroptosis-related genes as potential diagnostic biomarkers for osteoarthritis
por: Qiu, Yue, et al.
Publicado: (2023)

Emerging trends in DNA and RNA methylation modifications in type 2 diabetes mellitus: a bibliometric and visual analysis from 1992 to 2022
por: Jiang, Cai, et al.
Publicado: (2023)

Correction: Does DNA Methylation of PPARGC1A Influence Insulin Action in First Degree Relatives of Patients with Type 2 Diabetes?
por: Gillberg, Linn, et al.
Publicado: (2013)

Metabolomic comparison followed by cross-validation of enzyme-linked immunosorbent assay to reveal potential biomarkers of diabetic retinopathy in Chinese with type 2 diabetes
por: Wang, Zongyi, et al.
Publicado: (2022)

Risk factors associated with glycated hemoglobin A1c trajectories progressing to type 2 diabetes
por: Halalau, Alexandra, et al.
Publicado: (2023)

Maternal serum NGAL in the first trimester of pregnancy is a potential biomarker for the prediction of gestational diabetes mellitus
por: Lu, Ling, et al.
Publicado: (2022)

Identification of potential biomarkers and pathways associated with carotid atherosclerotic plaques in type 2 diabetes mellitus: A transcriptomics study
por: Yu, Tian, et al.
Publicado: (2022)

Identifying Common Genetic Risk Factors of Diabetic Neuropathies
por: Witzel, Ini-Isabée, et al.
Publicado: (2015)

DNA Methylation and Type 2 Diabetes: Novel Biomarkers for Risk Assessment?
por: Raciti, Gregory Alexander, et al.
Publicado: (2021)

Novel biomarkers and therapeutic approaches for diabetic retinopathy and nephropathy: Recent progress and future perspectives
por: Xie, Ziyan, et al.
Publicado: (2022)

Are the determinants of the progression to type 2 diabetes and regression to normoglycemia in the populations with pre-diabetes the same?
por: Alizadeh, Zeinab, et al.
Publicado: (2022)

Identification of copper-related biomarkers and potential molecule mechanism in diabetic nephropathy
por: Ming, Jie, et al.
Publicado: (2022)

Long non-coding RNAs in bone metastasis: progresses and perspectives as potential diagnostic and prognostic biomarkers
por: Maroni, Paola, et al.
Publicado: (2023)

Metabolomics study identified bile acids as potential biomarkers for gastric cancer: A case control study
por: Pan, Chen, et al.
Publicado: (2022)

Dyslipidemia and serum cystatin C levels as biomarker of diabetic nephropathy in patients with type 2 diabetes mellitus
por: Dejenie, Tadesse Asmamaw, et al.
Publicado: (2023)

Therapeutic Potential of Butyrate for Treatment of Type 2 Diabetes
por: Arora, Tulika, et al.
Publicado: (2021)

Phytochemicals as Potential Epidrugs in Type 2 Diabetes Mellitus
por: Ramírez-Alarcón, Karina, et al.
Publicado: (2021)

Clinical Potential of Extracellular Vesicles in Type 2 Diabetes
por: Liu, Jie, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_s7kodhtm90k6c47vl0c09hvtrc